Cargando…

The early-phase transcriptome and the clinical efficacy analysis in three modes of subcutaneous immunotherapy for allergic rhinitis

BACKGROUND: Allergen immunotherapy is the only etiological treatment for allergic rhinitis. OBJECTIVE: To analyze the efficacy, safety, and mechanism of subcutaneous immunotherapy (SCIT). METHODS: The efficacy, safety, and serum immunological changes of 3 modes of subcutaneous immunotherapy were com...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Jingyu, Zhang, Wei, Xiang, Rong, Tan, Lu, Liu, Peiqiang, Tao, Zezhang, Deng, Yuqin, Tong, Huan, Xu, Yu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	World Allergy Organization 2023
Materias:	Full Length Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10493265/ https://www.ncbi.nlm.nih.gov/pubmed/37701629 http://dx.doi.org/10.1016/j.waojou.2023.100811

Ejemplares similares

Efficacy and immunological changes of sublingual immunotherapy in pediatric allergic rhinitis
por: Zeng, Yinhui, et al.
Publicado: (2023)

Efficacy and safety of house dust mite sublingual immunotherapy tablets in allergic rhinitis: A systematic review and meta-analysis
por: Kulalert, Prapasri, et al.
Publicado: (2022)

Subcutaneous Immunotherapy Improves the Symptomatology of Allergic Rhinitis
por: Lourenço, Edmir Américo, et al.
Publicado: (2015)

Microbiome profiling of nasal extracellular vesicles in patients with allergic rhinitis
por: Chiang, Tsai-Yeh, et al.
Publicado: (2022)

Allergic rhinitis in Chinese young adults from the Singapore/Malaysia cross-sectional genetics epidemiology study (SMCGES) cohort: Prevalence, patterns, and epidemiology of allergic rhinitis
por: Wong, Qi Yi Ambrose, et al.
Publicado: (2022)

Safety of specific subcutaneous immunotherapy in patients with allergic rhinitis
por: Da Fonseca, Mario Henrique Almeida, et al.
Publicado: (2015)

Efficacy and Safety of Subcutaneous Allergen Immunotherapy for Allergic Rhinitis
por: Sohn, Myung Hyun
Publicado: (2018)

Specific immunoglobulin G4 correlates with Th2 cytokine reduction in patients with allergic asthma treated by Dermatophagoides pteronyssinus subcutaneous immunotherapy
por: Su, Qiujuan, et al.
Publicado: (2023)

Association between the genetic variants of base excision repair pathway genes and allergic rhinitis susceptibility in Chinese children
por: Liu, Wenlong, et al.
Publicado: (2022)

The efficacy of a novel smart watch on medicine adherence and symptom control of allergic rhinitis patients: Pilot study()
por: Li, Lisha, et al.
Publicado: (2023)

Prevalence and risk factors of allergic rhinitis among Chinese adults: A nationwide representative cross-sectional study
por: Zhang, Xiao, et al.
Publicado: (2023)

Birch-induced allergic rhinitis: Results of exposure during nasal allergen challenge, environmental chamber, and pollen season
por: Gherasim, Alina, et al.
Publicado: (2023)

Administration and burden of subcutaneous immunotherapy for allergic rhinitis in clinical practice in Canada
por: Blume, Steven W, et al.
Publicado: (2014)

Subcutaneous allergen immunotherapy with dermatophagoides pteronyssinus in patient with local allergic rhinitis
por: Rondon, Carmen, et al.
Publicado: (2015)

Safety Profile and Issues of Subcutaneous Immunotherapy in the Treatment of Children with Allergic Rhinitis
por: Endaryanto, Anang, et al.
Publicado: (2022)

Prevalence, severity, and risk factors of allergic rhinitis among schoolchildren in Saudi Arabia: A national cross-sectional study, 2019
por: Alnahas, Sawsan, et al.
Publicado: (2023)

Global expert views on the diagnosis, classification and pharmacotherapy of allergic rhinitis in clinical practice using a modified Delphi panel technique
por: Larenas-Linnemann, Désirée ES., et al.
Publicado: (2023)

Dropouts From Sublingual Immunotherapy and the Transition to Subcutaneous Immunotherapy in House Dust Mite-Sensitized Allergic Rhinitis Patients
por: Chen, Huan, et al.
Publicado: (2022)

Administration and Burden of Subcutaneous Immunotherapy for Allergic Rhinitis in U.S. and Canadian Clinical Practice
por: Blume, Steven W., et al.
Publicado: (2015)

Aeroallergen immunotherapy associated with reduced risk of severe COVID-19 in 1095 allergic patients
por: Larenas-Linnemann, Désirée, et al.
Publicado: (2023)

Comparison of Long-term Efficacy of Subcutaneous Immunotherapy in Pediatric and Adult Patients With Allergic Rhinitis
por: Huang, Yanran, et al.
Publicado: (2018)

Subcutaneous immunotherapy induces alterations in monocytes and dendritic cells homeostasis in allergic rhinitis patients
por: Sousa, Letícia, et al.
Publicado: (2018)

Effects of Serum Vitamin D and Efficacy of Subcutaneous Immunotherapy in Adult Patients With Allergic Rhinitis
por: Joudi, Maryam, et al.
Publicado: (2019)

Interactive Network Platform Improves Compliance and Efficacy of Subcutaneous Immunotherapy for Patients with Allergic Rhinitis
por: Shen, Zhiying, et al.
Publicado: (2019)

Efficacy of subcutaneous immunotherapy for patients with asthma and allergic rhinitis in Korea: effect on eosinophilic inflammation
por: Kim, Chang Keun, et al.
Publicado: (2021)

Nasal cytology can predict clinical efficacy of subcutaneous immunotherapy in intermittent allergic rhinitis
por: Jura-Szołtys, Edyta, et al.
Publicado: (2022)

Sublingual immunotherapy in allergic rhinitis
por: Han, Doo Hee, et al.
Publicado: (2011)

Changes of allergic inflammation and immunological parameters after Alt a 1 and A. alternata immunotherapy in mice
por: Liu, Juan, et al.
Publicado: (2023)

Efficacy and safety of subcutaneous immunotherapy with a mixture of glutaraldehyde-modified extracts of Dermatophagoides pteronyssinus, Dermatophagoides farinae, and Blomia tropicalis()
por: Cardona-Villa, Ricardo, et al.
Publicado: (2022)

Sublingual or Subcutaneous immunotherapy for Seasonal Allergic Rhinitis (AR): an indirect analysis of efficacy, safety and cost
por: Dranitsaris, George, et al.
Publicado: (2014)

Metabolomics Reveals Process of Allergic Rhinitis Patients with Single- and Double-Species Mite Subcutaneous Immunotherapy
por: Zheng, Peiyan, et al.
Publicado: (2021)

Can development of asthma and bronchial hyperreactivity be reduced by subcutaneous immunotherapy in adult patients with allergic rhinitis?
por: TEPETAM, Fatma Merve, et al.
Publicado: (2023)

Activation of Dopamine D2 Receptor Alleviates Neuroinflammation in a Mouse Model of Allergic Rhinitis With Olfactory Dysfunction
por: Liu, Peiqiang, et al.
Publicado: (2021)

Mechanisms of Allergen Immunotherapy in Allergic Rhinitis
por: Drazdauskaitė, Gabija, et al.
Publicado: (2020)

Immunotherapy in the Treatment of Allergic Rhinitis in Children
por: Alamri, Ruba A, et al.
Publicado: (2022)

Cluster Subcutaneous Allergen Specific Immunotherapy for the Treatment of Allergic Rhinitis: A Systematic Review and Meta-Analysis
por: Feng, Shaoyan, et al.
Publicado: (2014)

Impact of allergic rhinitis and specific subcutaneous immunotherapy on peripheral blood basophils of patients sensitized to Dermatophagoides pteronyssinus
por: Lopes, Ana, et al.
Publicado: (2013)

Short-Term Subcutaneous Allergy Immunotherapy and Dupilumab are Well Tolerated in Allergic Rhinitis: A Randomized Trial
por: Corren, Jonathan, et al.
Publicado: (2021)

Immunologic changes after house dust mite modified rush subcutaneous immunotherapy in allergic rhinitis children
por: Rattanamanee, Tipyapa, et al.
Publicado: (2022)

MIR222HG attenuates macrophage M2 polarization and allergic inflammation in allergic rhinitis by targeting the miR146a-5p/TRAF6/NF-κB axis
por: Wen, Silu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9uidkkr1e4ruef4890o2coa1aa